Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Outcomes of CTO PCI in a Non-surgical Centre
Author(s): Thomas R Gilpin , Annette Maznyczka , Brijesh Anantharam , et al Added: 1 year ago

Intervention

Prevention & Chronic Conditions
The Role of Non-invasive Tests in Pulmonary Embolism
Author(s): Ana Torremocha , Daniel Tébar , Alfonso Jurado-Román Added: 3 weeks ago

Imaging & Diagnostics

Intervention
Non-cardiac Surgery Interventions on Patients Receiving Impella Support
Author(s): Mark Anderson , Nicolas Brozzi , Raul Rosenthal , et al Added: 1 year ago

Intervention
Author(s): Mark Anderson , Hermann Reichenspurner , Alexander Bernhardt Added: 1 year ago

Intervention
The XLIMIT Trial: XLIMUS® DES Shows Non-Inferiority to Synergy™ DES
Author(s): Luca Testa Added: 1 year ago
Dr Luca Testa (IRCCS Policlinico San Donato, IT) discusses the results of the XLIMIT Trial at the EuroPCR 2024 congress in Paris, France.In this video interview, Dr Testa explains the technology behind the XLIMUS® drug-eluting stent (Cardionovum®) and its benefits. He also reviews the XLIMIT Trial, detailing the study design, selection criteria and clinical outcomes.Specifically, the 6 to 9… View more

Intervention
CRT 25: The PARTNER 3 Registry
Author(s): S. Chris Malaisrie Added: 7 months ago
CRT 25 - Dr S. Chris Malaisrie (Northwestern University, Evanston, US) joins us to discuss the five-year outcomes from the PARTNER 3 aortic valve-in-valve registry (NCT02675114). The prospective, randomized, multi-center study aimed to assess TAVR with the Edwards SAPIEN 3 transcatheter heart valve (Edwards Lifesciences) compared to aortic valve replacement with a commercially available surgical… View more

Intervention
TCT 24: Pooled Analysis of RHEIA and PARTNER 3
Author(s): Didier Tchétché Added: 1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) compared to surgical aortic valve replacement (SAVR) in female patients with severe aortic stenosis.Dr Didier Tchétché (Clinique Pasteur, FR) joins us onsite at TCT Conference to discuss the pooled findings from the RHEIA (NCT04160130) and PARTNER 3 (NCT02675114) trials.RHEIA and PARTNER 3 are… View more

Demographic

Intervention
Navigating Mitral and Tricuspid Valve Disease: Diagnosis, Quality of Life, and Patient-Centered Care
Author(s): , Start date: Aug 06, 2025
Mitral and tricuspid regurgitation remain under-recognised and undertreated despite their significant impact on symptoms, quality of life, and outcomes. In this expert-led webinar, Suzanne V. Arnold, MD (Saint Luke’s Health System, Kansas City, US) offers practical guidance on recognising heart valve disease early, navigating referral pathways, and integrating patient-centred data into everyday… View more

Intervention
OPTION–STEMI: Immediate Complete Revascularisation Fails to Show Non-Inferiority to Staged Approach
Added: 2 months ago Source:  Transcatheter Academy
The optimal timing for complete revascularisation in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease remains a topic of clinical debate.¹˒² The OPTION–STEMI trial aimed to determine whether an immediate complete revascularisation strategy was non-inferior to a staged approach performed during the same index hospital admission.¹OPTION–STEMI… View more

Guidelines & Statements

Intervention
Coronary Artery Ectasia in Acute Coronary Syndrome
Author(s): Mahmoud Izraiq , Nail Alshoubaki , Omran A Abu-Dhaim , et al Added: 11 months ago

Anticoagulation

Intervention